Théralpha

Science de la vie

  • :
  • :
  • :IPMC CNRS-UNSA

Development and marketing of new peptides for the treatment of neuropathic pain.

Théralpha

Theralpha is a biopharmaceutical company dedicated to developing and marketing new peptide-based products for the treatment of neuropathic, nociceptive and inflammatory pain.

The company was founded to develop and enhance the knowledge and intellectual property created by Professor Michel Lazdunski and his team at the Institut de Pharmacologie/CNRS, in Sophia Antipolis, in the field of analgesic peptides.